{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:00:57Z","timestamp":1785902457287,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["154144KYSB20150045"],"award-info":[{"award-number":["154144KYSB20150045"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["YJKYYQ20170036"],"award-info":[{"award-number":["YJKYYQ20170036"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Mega-project of China for Innovative Drugs","award":["2018ZX09721001-003-003"],"award-info":[{"award-number":["2018ZX09721001-003-003"]}]},{"name":"Main Infectious Diseases","award":["2017ZX10302301-003-002"],"award-info":[{"award-number":["2017ZX10302301-003-002"]}]},{"name":"Public Research and Capacity Building Project of Guangdong Province","award":["2017A020212004"],"award-info":[{"award-number":["2017A020212004"]}]},{"name":"Guangzhou Municipal Industry and Research Collaborative Innovation Programme","award":["201508020248"],"award-info":[{"award-number":["201508020248"]}]},{"name":"Guangzhou Municipal Industry and Research Collaborative Innovation Programme","award":["201604020019"],"award-info":[{"award-number":["201604020019"]}]},{"name":"Science and Technology Innovation Leader of Guangdong Province","award":["2016TX03R095"],"award-info":[{"award-number":["2016TX03R095"]}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.cmi.2018.12.008","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T22:33:30Z","timestamp":1545431610000},"page":"1041.e1-1041.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates"],"prefix":"10.1016","volume":"25","author":[{"given":"M.M.","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.A.","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chhotaray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Surineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.W.","family":"Yew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2018.12.008_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1084\/jem.20062100","article-title":"Mechanism of thioamide drug action against tuberculosis and leprosy","volume":"204","author":"Wang","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cmi.2018.12.008_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jgg.2016.10.002","article-title":"Drug resistance mechanisms and novel drug targets for tuberculosis therapy","volume":"44","author":"Islam","year":"2017","journal-title":"J\u00a0Genet Genomics"},{"key":"10.1016\/j.cmi.2018.12.008_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fcimb.2018.00114","article-title":"Molecular targets related drug resistance mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis strains","volume":"8","author":"Hameed","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.cmi.2018.12.008_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.8284673","article-title":"inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis","volume":"263","author":"Banerjee","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cmi.2018.12.008_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1128\/microbiolspec.MGM2-0014-2013","article-title":"Resistance to isoniazid and ethionamide in Mycobacterium tuberculosis: genes, mutations, and causalities","volume":"2","author":"Vilch\u00e8ze","year":"2014","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.cmi.2018.12.008_bib6","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1128\/AAC.01028-15","article-title":"Genotypic analysis of genes associated with independent resistance and cross-resistance to isoniazid and ethionamide in Mycobacterium tuberculosis clinical isolates","volume":"59","author":"Rueda","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.12.008_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijmyco.2016.11.020","article-title":"Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa","volume":"5","author":"Malinga","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.cmi.2018.12.008_bib8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1469-0691.2009.02838.x","article-title":"Genotypic analysis of genes associated with isoniazid and ethionamide resistance in MDR-TB isolates from Thailand","volume":"16","author":"Boonaiam","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.12.008_bib9","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.5588\/ijtld.15.0864","article-title":"Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis","volume":"20","author":"Bollela","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2018.12.008_bib10","first-page":"441","article-title":"Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea","volume":"4","author":"Lee","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2018.12.008_bib11","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1073\/pnas.97.17.9677","article-title":"Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis","volume":"97","author":"DeBarber","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cmi.2018.12.008_bib12","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/AAC.00112-06","article-title":"Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis","volume":"50","author":"Hazb\u00f3n","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.12.008_bib13","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/jac\/dku161","article-title":"Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates","volume":"69","author":"Jagielski","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.12.008_bib14","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1128\/AAC.47.12.3799-3805.2003","article-title":"ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates","volume":"47","author":"Morlock","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.12.008_bib15","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3389\/fmicb.2017.02358","article-title":"Molecular characterization of prothionamide-resistant Mycobacterium tuberculosis isolates in southern China","volume":"8","author":"Tan","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2018.12.008_bib16","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1128\/AAC.45.7.2157-2159.2001","article-title":"Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates","volume":"45","author":"Lee","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.12.008_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1128\/AAC.01030-10","article-title":"Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug resistant clinical isolates of Mycobacterium tuberculosis","volume":"55","author":"Brossier","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.12.008_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2958.2003.03809.x","article-title":"EthR, a repressor of the TetR\/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator","volume":"51","author":"Engohang-Ndong","year":"2004","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.cmi.2018.12.008_bib19","doi-asserted-by":"crossref","first-page":"28326","DOI":"10.1074\/jbc.M003744200","article-title":"Activation of the prodrug ethionamide is regulated in mycobacteria","volume":"275","author":"Baulard","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cmi.2018.12.008_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000351","article-title":"Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study","volume":"1","author":"Balabanova","year":"2011","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2018.12.008_bib21","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1183\/13993003.00438-2016","article-title":"Efficacy and tolerability of ethionamide versus prothionamide: a systematic review","volume":"48","author":"Scardigli","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2018.12.008_bib22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1186\/s12879-017-2761-6","article-title":"Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China","volume":"17","author":"Pang","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2018.12.008_bib23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/AAC.01228-13","article-title":"Prevalence and molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates in China","volume":"58","author":"Zhang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.12.008_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ng.2878","article-title":"Evolution and transmission of drug-resistant tuberculosis in a Russian population","volume":"46","author":"Casali","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.cmi.2018.12.008_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1054\/tuld.1999.0231","article-title":"Genomic mutations in the katG, inhA, and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa","volume":"80","author":"Kiepiela","year":"2000","journal-title":"Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2018.12.008_bib26","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/JCM.41.9.4471-4474.2003","article-title":"Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis","volume":"41","author":"Silva","year":"2003","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.12.008_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jmii.2013.08.018","article-title":"The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan","volume":"48","author":"Tseng","year":"2015","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.cmi.2018.12.008_bib28","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/jac\/dkm086","article-title":"Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation","volume":"59","author":"Afanas'ev","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.12.008_bib29","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3892\/mmr.2014.2045","article-title":"Analysis of mutational characteristics of the drug-resistant gene katG in multi-drug resistant Mycobacterium tuberculosis L-form among patients with pneumoconiosis complicated with tuberculosis","volume":"9","author":"Lu","year":"2014","journal-title":"Mol Med Rep"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18307948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18307948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:23:26Z","timestamp":1761117806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X18307948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1198743X18307948"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2018.12.008","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2018.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}